Max Hodak
Overview
Contents8 sections
Key facts
Topic: Childhood, university and his first company
Hodak was born in Princeton, New JerseyNew JerseyNew Jersey is a state in the eastern United States on the Atlantic Ocean, bordered by New York State, Delaware, and Pennsylvania, with the Hudson River forming its northeastern boundary and the Delaware River its western boundary; its capital is Trenton and its largest city is Newark. One of the original 13 colonies, it became the third state to ratify the U.S. Constitution on December 18, 1787, and its population in the 2020 census (April 1, 2020) was 9,288,994.Open the full entry, and moved with his family to Manhattan at two. He recalled watching The Matrix in fifth grade as an early influence on his interest in consciousness and perception, and described his parents’ support for his exploration of science. At Duke University he worked as a research assistant in Miguel Nicolelis’s laboratory on brain-computer interfaces, earning his bachelor’s degree in biomedical engineering in 2012.[3][4][1]
He began work on MyFit in high school to help students estimate their chances of admission to college. After his sophomore year he took a year away from Duke for the education technology business, which he later sold to an admissions management company. Back in school, he traveled frequently between college and his entrepreneurial work.[4]
Topic: From Transcriptic to Science Corporation
He founded Transcriptic in 2012 to provide laboratory services over the internet and served as CEO until 2017. In 2019 it merged with 3Scan and became Strateos. He was also a co-founder and president of Neuralink and left in early 2021. Duke dates his co-founding of Neuralink to 2016. His own profile dates his departure as Transcriptic CEO to work on Neuralink to 2017.[4][1]
In 2021 he and collaborators founded Science Corporation. It acquired the PRIMA retinal implant system from Paris-based Pixium Vision and continued research into whether it could restore functional central vision in people with advanced macular degeneration.[1]
Interview: No Priors
On August 20, 2026, Hodak told Sarah GuoSarah GuoSarah Guo is a venture capitalist, founder and managing partner of Conviction, an early-stage investment firm focused on artificial intelligence, and previously a partner at Greylock.Open the full entry about the origins of Science and used PRIMA to discuss the engineering and clinical questions facing vision-restoration research. They also explored how the senses relate to the brain and how engineering research might inform the study of consciousness.[2]
Advice Shared on No Priors
In discussing research planning, he suggested pairing a long and uncertain research program with a nearer-term business. (03:25)[2]
He described starting with what would help patients most given the team's resources and the state of research. That question shaped its decision to pursue vision restoration in 2021. (03:31)[2]
Related Organizations, Websites and Public Accounts
Science Corporation: Co-founder and CEO. Official website: https://science.xyz/ (opens in a new window).[1]
Personal website: https://maxhodak.com/ (opens in a new window).[5]
August 20, 2026Interview with No Priors
He recalled trial participants doing Sudoku or crossword puzzles and others reading books. He saw those individual outcomes as evidence that the approach warranted further work.[2]
Sources5 sources
- Spotlight: Portfolio Founder Max Hodak (opens in a new window)dukecapitalpartners.duke.edu↑
- From Restoring Sight to Reimagining the Brain, with Max Hodak (opens in a new window)youtube.com↑
- Max Hodak’s Quest for Consciousness (opens in a new window)arenamagazine.substack.com↑
- About Max (opens in a new window)maxhodak.com↑
- Max Hodak (opens in a new window)maxhodak.com↑